Loading...
OTCM
ZIVO
Market cap38mUSD
Dec 05, Last price  
10.00USD
1D
0.00%
1Q
-32.66%
Jan 2017
-78.07%
IPO
-84.32%
Name

Zivo Bioscience Inc

Chart & Performance

D1W1MN
OTCM:ZIVO chart
P/E
P/S
247.33
EPS
Div Yield, %
Shrs. gr., 5y
42.73%
Rev. gr., 5y
%
Revenues
157k
+468.61%
95,967297,295161,340176,90379,14082,725103,8910000000020,0000027,650157,220
Net income
-13m
L+72.10%
-5,956,895-3,541,223-2,250,988-1,813,840-1,416,860-7,122,473-2,731,610-3,248,405-10,095,878680,811-5,789,131-6,059,627-10,038,374-14,635,367-14,667,982-9,655,783-9,396,647-8,745,293-7,777,184-13,384,836
CFO
-4m
L-25.63%
-1,649,480-2,089,257-1,406,740-935,823-1,150,119-1,439,727-1,294,128-1,773,264-2,986,213-2,736,046-2,296,887-2,543,473-4,242,891-5,006,586-3,707,297-2,588,415-6,803,333-7,102,612-5,799,893-4,313,510

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. It operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan.
IPO date
Oct 06, 2000
Employees
8
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT